Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2020-10-19
2021-09-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ImpleMEntation of a Digital-first Care deLiverY Model for Heart Failure in Uganda
NCT05955937
An Innovative Mobile Health Intervention to Improve Self-care in Patients With Heart Failure
NCT04262544
Heart Failure Self-care With the Aid of a Smartphone Application
NCT03194841
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
NCT06205225
Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure
NCT03642275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mHealth
Heart failure patients enrolled in the mHealth program
mHealth for heart failure patients in Uganda
Patients at Uganda Heart Institute will be enrolled in an mHealth program intended to promote self-care for heart failure and improve their healthcare quality of life.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mHealth for heart failure patients in Uganda
Patients at Uganda Heart Institute will be enrolled in an mHealth program intended to promote self-care for heart failure and improve their healthcare quality of life.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently living in Uganda and not planning to travel abroad for six months
* Age \>=18 years
* Symptomatic heart failure (New York Heart Association Class II or III and left ventricular ejection fraction of 45% or less)
* Access to a mobile phone
* Basic reading skills in English, Luganda, and/or Runyankole
Exclusion Criteria
* Active medical condition requiring hospitalization, such as cardiac ischemia (acute electrocardiographic changes and/or positive biomarkers, if available), syncope, or significant fluid overload
* Pregnancy
* Inability to provide informed consent.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fogarty International Center of the National Institute of Health
NIH
Makerere University
OTHER
Uganda Heart Institute
OTHER
University Health Network, Toronto
OTHER
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeremy Schwartz, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Isaac Ssinabulya, MMed
Role: PRINCIPAL_INVESTIGATOR
Uganda Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uganda Heart Institute
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000025338
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.